|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-06
|
$238,147
|
$14,289
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Immuno/Immunogene Therapies for Thoracic Malignancies
|
5P01CA066726-13
|
$1,203,367
|
$601,684
|
Albelda, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$483,295
|
$120,824
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$7,852
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$25,042
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-19
|
$687,330
|
$13,747
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Southwest Oncology Group
|
5U10CA027057-30
|
$267,015
|
$2,670
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-30
|
$9,379,270
|
$93,793
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-25
|
$10,708,109
|
$107,081
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Growth Control in Multiple Myeloma
|
2P01CA055819-15
|
$3,715,800
|
$371,580
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Growth Control in Multiple Myeloma
|
3P01CA055819-14S1
|
$849,984
|
$84,998
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-03
|
$507,986
|
$5,080
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Iowa Oncology Research Association
|
5U10CA035101-24
|
$865,544
|
$8,655
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
The role of Toll-like receptor 3 in overcoming cancer immunoediting
|
5K22CA122828-03
|
$162,035
|
$40,509
|
Bell, Jessica
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-34
|
$460,085
|
$27,605
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$735
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$590
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$846
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$68,965
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-26
|
$610,000
|
$6,100
|
Bernath, Albert
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,020,404
|
$202,040
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Southwest Oncology Group
|
5U10CA004919-50
|
$195,727
|
$1,957
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
The function and regulation of histocompatibility antigen 60 in cancer
|
5K08CA128893-02
|
$126,755
|
$126,755
|
BUI, JACK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
The role of cellular miRNA in Epstein-Barr virus oncogenesis
|
5F32CA130469-02
|
$55,310
|
$13,828
|
Cameron, Jennifer
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Novel Approaches to Stem Cell Transplantation
|
2P01CA047741-16A1
|
$1,827,050
|
$274,058
|
CHAO, NELSON
|
DUKE UNIVERSITY
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
|
5U10CA021115-35
|
$9,256,982
|
$555,419
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
ECOG CCOP Research Base
|
5U10CA037403-24
|
$2,330,240
|
$69,907
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
Eastern Cooperative Oncology Group Chair's Office
|
5U10CA086802-11
|
$655,420
|
$39,325
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-24
|
$4,746,162
|
$47,462
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Community Clinical Oncology Program
|
5U10CA035431-26
|
$1,889,840
|
$18,898
|
DAKHIL, SHAKER
|
VIA CHRISTI REGIONAL MEDICAL CENTER
|
|
Cancer Center Support
|
3P30CA047904-21S2
|
$5,021,590
|
$188,812
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Targeting myeloma via dendritic cells
|
5R01CA109465-05
|
$309,925
|
$77,481
|
DHODAPKAR, MADHAV
|
YALE UNIVERSITY
|
|
SPORE in Genitourinary Cancer
|
5P50CA091846-09
|
$2,233,299
|
$446,660
|
DINNEY, COLIN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE in Breast Cancer
|
5P50CA058223-17
|
$2,119,686
|
$211,969
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-22
|
$83,653
|
$837
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Nevada Cancer Research Foundation-Community Clinical Oncology Program
|
5U10CA035421-26
|
$762,058
|
$7,621
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Immunotherapy for Renal Cell Carcinoma
|
5R01CA095648-05
|
$405,348
|
$101,337
|
ERNSTOFF, MARC
|
DARTMOUTH COLLEGE
|
|
SWOG Institutional Grant
|
5U10CA073590-13
|
$110,426
|
$6,626
|
FERNANDEZ, HUGO
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Antigen processing and HLA-peptide complexes in head and neck cancer
|
5R01CA110249-04
|
$320,085
|
$80,021
|
FERRONE, SOLDANO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Southwest Oncology Group
|
5U10CA011083-42
|
$359,154
|
$3,592
|
FISHER, RICHARD
|
UNIVERSITY OF ROCHESTER
|
|
Quality Assurance Review Center
|
5U10CA029511-30
|
$1,737,151
|
$17,372
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Southwest Oncology Group
|
5U10CA014028-36
|
$221,046
|
$2,210
|
FLAHERTY, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
Metro-Minnesota Community Clinical Oncology Program
|
5U10CA035267-26
|
$1,733,996
|
$17,340
|
FLYNN, PATRICK
|
PARK NICOLLET INSTITUTE
|
|
Eastern Cooperative Oncology Group
|
5U10CA016116-36
|
$284,348
|
$17,061
|
FORASTIERE, ARLENE
|
JOHNS HOPKINS UNIVERSITY
|
|
Ochsner Community Clinical Oncology Program
|
5U10CA035272-26
|
$437,608
|
$4,376
|
FULORIA, JYOTSNA
|
OCHSNER CLINIC FOUNDATION
|
|
A Critical Role for Stat2 in Type 1 Intferon-Induced Apoptosis
|
5K22CA095326-02
|
$160,515
|
$160,515
|
GAMERO, ANA
|
TEMPLE UNIVERSITY
|
|
Southwest Oncology Group/ University of California,
|
5U10CA046441-22
|
$348,516
|
$3,485
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S2
|
$70,196
|
$597
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S3
|
$99,890
|
$849
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-20
|
$4,865,452
|
$41,356
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
Total relevant funding to Interferon for this search: $15,096,924
|